CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.63%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.21B
AUM Growth
+$7.21B
(+11%)
Cap. Flow
+$312M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
73.33%
Holding
137
New
11
Increased
45
Reduced
45
Closed
6
Top Buys
| 1 |
Coca-Cola
KO
|
$300M |
| 2 |
Procter & Gamble
PG
|
$113M |
| 3 |
HDFC Bank
HDB
|
$15.9M |
| 4 |
Merck
MRK
|
$7.84M |
| 5 |
Alkermes
ALKS
|
$6.65M |
Top Sells
| 1 |
TSMC
TSM
|
$71.3M |
| 2 |
Visa
V
|
$18.7M |
| 3 |
Home Depot
HD
|
$9.69M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$9.36M |
| 5 |
Glaukos
GKOS
|
$8.09M |
Sector Composition
| 1 | Financials | 29.05% |
| 2 | Consumer Discretionary | 18.26% |
| 3 | Communication Services | 15.15% |
| 4 | Healthcare | 13.9% |
| 5 | Consumer Staples | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Merck
MRK
$210B
| $20M | 0.28% | 329,955 +129,138 | +64% | +$7.84M |
|
27
Pfizer
PFE
$141B
| $18.9M | 0.26% | 520,564 -28,815 | -5% | -$1.05M |
|
28
Gilead Sciences
GILD
$140B
| $17.4M | 0.24% | 245,983 -32,887 | -12% | -$2.33M |
|
|
AGN
29
DELISTED
Allergan plc
AGN
| $14.2M | 0.2% | 85,101 | – | – |
|
30
Biogen
BIIB
$19.4B
| $14.1M | 0.2% | 48,586 | – | – |
|
31
Edwards Lifesciences
EW
$47.8B
| $13.5M | 0.19% | 92,393 | – | – |
|
|
SHPG
32
DELISTED
Shire pic
SHPG
| $13.3M | 0.18% | 78,678 -935 | -1% | -$158K |
|
33
AbbVie
ABBV
$372B
| $13.3M | 0.18% | 143,271 | – | – |
|
34
Becton Dickinson
BDX
$55.3B
| $12.7M | 0.18% | 52,955 | – | – |
|
35
Dynavax Technologies
DVAX
$1.19B
| $12.1M | 0.17% | 794,747 +52,732 | +7% | +$804K |
|
36
Boston Scientific
BSX
$156B
| $12M | 0.17% | 367,194 | – | – |
|
37
Viatris
VTRS
$12.3B
| $12M | 0.17% | 330,668 +53,642 | +19% | +$1.94M |
|
38
Centene
CNC
$14.3B
| $11.5M | 0.16% | 93,653 | – | – |
|
39
Vertex Pharmaceuticals
VRTX
$100B
| $11M | 0.15% | 64,530 +16,134 | +33% | +$2.74M |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $9.77M | 0.14% | 123,070 -1,400 | -1% | -$111K |
|
41
Insmed
INSM
$28.8B
| $9.72M | 0.13% | 410,954 +38,292 | +10% | +$906K |
|
|
ALXN
42
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.38M | 0.13% | 75,574 | – | – |
|
|
ESRX
43
DELISTED
Express Scripts Holding Company
ESRX
| $9.24M | 0.13% | 119,604 | – | – |
|
44
Sarepta Therapeutics
SRPT
$1.78B
| $9.18M | 0.13% | 69,427 +2,155 | +3% | +$285K |
|
45
Jazz Pharmaceuticals
JAZZ
$7.75B
| $8.55M | 0.12% | 49,592 | – | – |
|
46
Heron Therapeutics
HRTX
$207M
| $8.2M | 0.11% | 211,012 +97,002 | +85% | +$3.77M |
|
47
HCA Healthcare
HCA
$94.5B
| $8.16M | 0.11% | 79,535 | – | – |
|
48
Eli Lilly
LLY
$657B
| $7.84M | 0.11% | 91,848 -33,272 | -27% | -$2.84M |
|
49
DexCom
DXCM
$29.5B
| $7.66M | 0.11% | 80,603 +17,420 | +28% | +$1.65M |
|
|
AERI
50
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.49M | 0.1% | 110,838 +38,099 | +52% | +$2.57M |
|